Schonfeld Strategic Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $428K | Buy |
+5,965
| New | +$460K | ﹤0.01% | 1451 |
|
|
2025
Q4 | – | Sell |
-7,732
| Closed | -$583K | – | 2146 |
|
|
2025
Q3 | $583K | Sell |
7,732
-137,726
| -95% | -$9.44M | ﹤0.01% | 1624 |
|
|
2025
Q2 | $10M | Buy |
145,458
+1,416
| +1% | +$92.9K | 0.07% | 340 |
|
|
2025
Q1 | $9.76M | Buy |
144,042
+130,369
| +953% | +$7.8M | 0.06% | 331 |
|
|
2024
Q4 | $614K | Sell |
13,673
-95,147
| -87% | -$5.34M | ﹤0.01% | 1314 |
|
|
2024
Q3 | $6.84M | Buy |
108,820
+78,637
| +261% | +$4.59M | 0.05% | 420 |
|
|
2024
Q2 | $1.78M | Buy |
+30,183
| New | +$1.89M | 0.01% | 953 |
|
|
2024
Q1 | – | Sell |
-152,708
| Closed | -$12.1M | – | 2125 |
|
|
2023
Q4 | $12.1M | Sell |
152,708
-23,120
| -13% | -$1.65M | 0.08% | 294 |
|
|
2023
Q3 | $12.3M | Buy |
175,828
+50,923
| +41% | +$3.61M | 0.1% | 296 |
|
|
2023
Q2 | $8.63M | Sell |
124,905
-74,767
| -37% | -$5.32M | 0.07% | 377 |
|
|
2023
Q1 | $14.8M | Sell |
199,672
-26,306
| -12% | -$2.21M | 0.14% | 203 |
|
|
2022
Q4 | $21.1M | Buy |
225,978
+84,838
| +60% | +$8.19M | 0.18% | 161 |
|
|
2022
Q3 | $13.5M | Sell |
141,140
-124,617
| -47% | -$12.3M | 0.11% | 254 |
|
|
2022
Q2 | $24.6M | Buy |
265,757
+160,648
| +153% | +$15.7M | 0.24% | 105 |
|
|
2022
Q1 | $10.6M | Sell |
105,109
-8,379
| -7% | -$880K | 0.1% | 254 |
|
|
2021
Q4 | $11.7M | Sell |
113,488
-18,719
| -14% | -$1.73M | 0.11% | 252 |
|
|
2021
Q3 | $11.2M | Buy |
132,207
+107,207
| +429% | +$8.98M | 0.12% | 228 |
|
|
2021
Q2 | $2.09M | Sell |
25,000
-405,587
| -94% | -$33.2M | 0.02% | 692 |
|
|
2021
Q1 | $32.4M | Buy |
430,587
+420,587
| +4,206% | +$30.6M | 0.39% | 37 |
|
|
2020
Q4 | $683K | Sell |
10,000
-87,200
| -90% | -$5.67M | 0.01% | 935 |
|
|
2020
Q3 | $5.68M | Sell |
97,200
-76,765
| -44% | -$4.78M | 0.11% | 256 |
|
|
2020
Q2 | $11.3M | Buy |
173,965
+107,881
| +163% | +$6.79M | 0.29% | 75 |
|
|
2020
Q1 | $3.92M | Buy |
+66,084
| New | +$4.41M | 0.25% | 86 |
|
|
2019
Q4 | – | Sell |
-89,400
| Closed | -$5.64M | – | 1321 |
|
|
2019
Q3 | $5.64M | Sell |
89,400
-238,200
| -73% | -$14.1M | 0.17% | 158 |
|
|
2019
Q2 | $17.9M | Buy |
327,600
+39,578
| +14% | +$2.13M | 0.63% | 30 |
|
|
2019
Q1 | $15.5M | Buy |
288,022
+177,428
| +160% | +$11M | 0.54% | 30 |
|
|
2018
Q4 | $7.25M | Buy |
+110,594
| New | +$8.26M | 0.28% | 87 |
|
|
2016
Q4 | – | Sell |
-4,502
| Closed | -$401K | – | 562 |
|
|
2016
Q3 | $401K | Sell |
4,502
-14,471
| -76% | -$1.37M | 0.07% | 290 |
|
|
2016
Q2 | $1.82M | Buy |
+18,973
| New | +$1.89M | 0.41% | 61 |
|
Other funds holding CVS
VCM
VPM
Schonfeld Strategic Advisors's CVS Position: Q1 2026 in Review
Schonfeld Strategic Advisors opened a new position in CVS Health (CVS) in Q1 2026: 5,965 shares worth $428K. The stake represents ﹤0.01% of the portfolio and ranks #1451 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in CVS as recently as Q3 2025.
Schonfeld Strategic Advisors first reported a position in CVS in Q2 2016 and has held it in 29 quarters since. The position peaked at $32.4M in Q1 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Schonfeld Strategic Advisors held 5,965 shares of CVS Health worth $428K as of Q1 2026.
- CVS Health was a new Schonfeld Strategic Advisors position in Q1 2026.
- CVS Health made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1451 holding.
- Schonfeld Strategic Advisors first reported a position in CVS Health in Q2 2016 and has held it in 29 quarters since.
- Schonfeld Strategic Advisors's CVS Health position peaked at $32.4M in Q1 2021.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.